Total Payments
$17,392
2024 Payments
$2,107
Companies
63
Transactions
1,103
Medicare Patients
6,575
Medicare Billing
$934,932
Payment Breakdown by Category
Food & Beverage$17,144 (98.6%)
Education$229.84 (1.3%)
Other$17.98 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,144 | 1,091 | 98.6% |
| Education | $229.84 | 11 | 1.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $17.98 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,767 | 196 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,502 | 89 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,317 | 78 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,030 | 82 | $0 (2023) |
| ABBVIE INC. | $828.52 | 59 | $0 (2024) |
| Lilly USA, LLC | $692.84 | 52 | $0 (2024) |
| Amgen Inc. | $637.35 | 40 | $0 (2024) |
| GlaxoSmithKline, LLC. | $627.65 | 48 | $0 (2024) |
| Merck Sharp & Dohme LLC | $584.86 | 44 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $551.76 | 50 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,107 | 95 | AstraZeneca Pharmaceuticals LP ($482.14) |
| 2023 | $2,126 | 105 | Novo Nordisk Inc ($349.04) |
| 2022 | $2,208 | 120 | AstraZeneca Pharmaceuticals LP ($386.59) |
| 2021 | $2,124 | 136 | Novo Nordisk Inc ($421.18) |
| 2020 | $1,840 | 117 | Boehringer Ingelheim Pharmaceuticals, Inc. ($252.11) |
| 2019 | $2,461 | 167 | Janssen Pharmaceuticals, Inc ($354.59) |
| 2018 | $2,291 | 171 | Novo Nordisk Inc ($553.75) |
| 2017 | $2,236 | 192 | AstraZeneca Pharmaceuticals LP ($294.88) |
All Payment Transactions
1,103 individual payment records from CMS Open Payments — Page 1 of 45
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 12/04/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Obesity | ||||||
| 11/18/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: UROLOGY | ||||||
| 11/13/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: EPILEPSY | ||||||
| 11/13/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: DIABETES | ||||||
| 10/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $8.41 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Obesity | ||||||
| 10/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Respiratory | ||||||
| 10/02/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.37 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.87 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/18/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $8.16 | General |
| 09/17/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $35.60 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 09/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Oncology | ||||||
| 09/09/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,220 | 2,688 | $502,834 | $193,812 |
| 2022 | 15 | 1,283 | 2,869 | $522,534 | $180,820 |
| 2021 | 22 | 1,748 | 4,018 | $694,800 | $252,292 |
| 2020 | 23 | 2,324 | 5,038 | $870,782 | $308,008 |
Total Patients
6,575
Total Services
14,613
Medicare Billing
$934,932
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 166 | 1,132 | $210,552 | $87,228 | 41.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 312 | 552 | $124,200 | $45,474 | 36.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 213 | 378 | $57,834 | $23,305 | 40.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 164 | 164 | $55,924 | $21,102 | 37.7% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 76 | 78 | $21,840 | $7,921 | 36.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 60 | 67 | $11,658 | $2,723 | 23.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $5,291 | $1,822 | 34.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 67 | 125 | $5,125 | $1,172 | 22.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 35 | 35 | $2,625 | $1,058 | 40.3% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 18 | 27 | $3,591 | $883.44 | 24.6% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 35 | 35 | $2,065 | $766.50 | 37.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 18 | $1,350 | $183.68 | 13.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 38 | 49 | $490.00 | $107.80 | 22.0% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 12 | 17 | $289.00 | $65.45 | 22.6% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 174 | 1,085 | $201,810 | $68,588 | 34.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 311 | 551 | $123,975 | $43,592 | 35.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 241 | 471 | $72,063 | $27,394 | 38.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 150 | 150 | $51,150 | $19,283 | 37.7% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 81 | 82 | $22,960 | $8,022 | 34.9% |
| 99335 | Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | Office | 2022 | 20 | 92 | $18,308 | $6,172 | 33.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 59 | 73 | $12,702 | $3,094 | 24.4% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2022 | 33 | 52 | $6,916 | $1,500 | 21.7% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 84 | 156 | $6,396 | $1,480 | 23.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 24 | 24 | $1,800 | $687.84 | 38.2% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 25 | 25 | $1,475 | $506.16 | 34.3% |
About Dr. Ernest De Leon, MD
Dr. Ernest De Leon, MD is a Family Medicine healthcare provider based in Lake City, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558454603.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ernest De Leon, MD has received a total of $17,392 in payments from pharmaceutical and medical device companies, with $2,107 received in 2024. These payments were reported across 1,103 transactions from 63 companies. The most common payment nature is "Food and Beverage" ($17,144).
As a Medicare-enrolled provider, De Leon has provided services to 6,575 Medicare beneficiaries, totaling 14,613 services with total Medicare billing of $934,932. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Lake City, FL
- Active Since 10/02/2006
- Last Updated 02/10/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1558454603
Products in Payments
- FARXIGA (Drug) $1,362
- Ozempic (Drug) $1,159
- JARDIANCE (Drug) $1,052
- XARELTO (Drug) $736.87
- BREZTRI (Drug) $595.06
- VRAYLAR (Drug) $484.59
- Victoza (Drug) $443.87
- Rybelsus (Drug) $401.54
- Wegovy (Drug) $342.90
- JANUVIA (Drug) $309.42
- UBRELVY (Drug) $302.78
- Aimovig (Biological) $300.72
- INVOKANA (Drug) $293.37
- TRELEGY ELLIPTA (Drug) $256.04
- EMGALITY (Drug) $250.84
- QULIPTA (Drug) $223.71
- Livalo (Drug) $218.08
- ANORO (Drug) $215.89
- GEMTESA (Drug) $214.91
- SYMBICORT (Drug) $212.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lake City
Miguel Tepedino, Md, MD
Family Medicine — Payments: $71,706
Family Medicine $71,706
Dr. Richard Wright, M.d, M.D
Family Medicine — Payments: $17,641
Family Medicine $17,641
Dr. David Moon, M.d, M.D
Family Medicine — Payments: $13,012
Family Medicine $13,012
Dr. Daniel Decamps, M.d, M.D
Family Medicine — Payments: $11,529
Family Medicine $11,529
Jean-Felert Cadet, M.d Mph, M.D MPH
Family Medicine — Payments: $5,750
Family Medicine $5,750
Dr. David Rodriguez, M.d, M.D
Family Medicine — Payments: $5,322
Family Medicine $5,322